Table 1.
Patient Data
| A. Enzymology assay patient data
| ||||
|---|---|---|---|---|
| Specimen | Sample ID | Cancer | Histology | Pathology Stage |
| Breast | 1 | Breast | Infiltrating duct carcinoma | IIB |
| 2 | Breast | Infiltrating duct mixed with other types of carcinoma | IIB | |
| 3 | Breast | Comedocarcinomanon-infiltrating | 0 | |
| 4 | Breast | Infiltrating duct and lobular carcinoma | IIB | |
| 5 | Breast | Infiltrating duct carcinoma | IIA | |
| 6 | Breast | Infiltrating duct carcinoma | IIIB | |
|
| ||||
| Colon | 1 | Colorectal | Adenocarcinoma | IIA |
| 2 | Colorectal | Adenocarcinoma | IV | |
| 3 | Colorectal | Adenocarcinoma | IIIC | |
| 4 | Colon | Adenocarcinoma | - | |
| 5 | Colon | Serous surface papillary carcinoma | - | |
| 6 | Colon | Adenocarcinoma | IIA | |
|
| ||||
| Prostate | 1 | Prostate | Adenocarcinoma | III |
| 2 | Prostate | Adenocarcinoma | II | |
| 3 | Prostate | Adenocarcinoma | III | |
| 4 | Prostate | Adenocarcinoma | - | |
| 5 | Prostate | Adenocarcinoma | II | |
| B. Breast tumor microarray patient data
| |||||||
|---|---|---|---|---|---|---|---|
| Parameter vs # of patients | |||||||
| Diagnosis Age | # | Tumor size | # | Pathological stage | # | Node stage | # |
| 25–35 | 5 | T1 | 67 | IIA | 47 | N0 | 31 |
| 35–45 | 22 | T2 | 13 | IIB | 45 | N1 | 74 |
| 45–55 | 27 | T3 | 15 | IIIA | 8 | N2 | 3 |
| 55–65 | 33 | T4 | 20 | IIIB | 12 | N3 | 7 |
| 65–75 | 15 | IIIC | 1 | ||||
| 75–95 | 13 | IV | 2 | ||||
|
| |||||||
| Metastatic | # | ER | # | PR | # | HER-2 | # |
| M0 | 113 | Positive | 101 | Positive | 77 | Negative | 90 |
| M1 | 2 | Negative | 13 | Negative | 37 | Weak | 13 |
| Not determined | 1 | Not determined | 1 | Strong | 11 | ||